Literature DB >> 16039953

Phenotypic characterization of chondrosarcoma-derived cell lines.

C M Schörle1, F Finger, A Zien, J A Block, P M Gebhard, T Aigner.   

Abstract

Gene expression profiling of three chondrosarcoma derived cell lines (AD, SM, 105KC) showed an increased proliferative activity and a reduced expression of chondrocytic-typical matrix products compared to primary chondrocytes. The incapability to maintain an adequate matrix synthesis as well as a notable proliferative activity at the same time is comparable to neoplastic chondrosarcoma cells in vivo which cease largely cartilage matrix formation as soon as their proliferative activity increases. Thus, the investigated cell lines are of limited value as substitute of primary chondrocytes but might have a much higher potential to investigate the behavior of neoplastic chondrocytes, i.e. chondrosarcoma biology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16039953     DOI: 10.1016/j.canlet.2004.11.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  A thin-layer model for viscoelastic, stress-relaxation testing of cells using atomic force microscopy: do cell properties reflect metastatic potential?

Authors:  Eric M Darling; Stefan Zauscher; Joel A Block; Farshid Guilak
Journal:  Biophys J       Date:  2006-12-08       Impact factor: 4.033

2.  Characterization of a stretch-activated potassium channel in chondrocytes.

Authors:  Ali Mobasheri; Rebecca Lewis; Judith E J Maxwell; Claire Hill; Matthew Womack; Richard Barrett-Jolley
Journal:  J Cell Physiol       Date:  2010-05       Impact factor: 6.384

3.  rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ.

Authors:  Henning Madry; Jagadeesh K Venkatesan; Gertrud Schmitt; Sarah Schetting; Myriam Ekici; Dieter Kohn; Magali Cucchiarini
Journal:  Sarcoma       Date:  2012-05-07

4.  Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2.

Authors:  Xiaoyang Li; Dylan C Dean; Al Ferreira; Scott D Nelson; Francis J Hornicek; Shengji Yu; Zhenfeng Duan
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.